BioSpace News Archive

New Research on Migraine in the Workplace Unveiled During Press Conference to be Broadcast via Facebook Live from the World Congress of Neurology, Dubai, Oct. 29, 8 a.m. GST

The XXIV World Congress of Neurology is bringing together leading voices in migraine research and advocacy to share vital insights on the global impact of migraine in the workplace.

October 27, 2019
·
5 min read
Business

Regenstrief scientist honored for research to support clinical decision making

The Society for Medical Decision Making awarded Regenstrief Institute researcher Stephen Downs, M.D., M.S., with the John M. Eisenberg Award for Practical Application of Medical Decision Making Research.

October 27, 2019
·
3 min read
Business

CELLINK opens office in Lyon, France to strengthen presence in Europe

CELLINK has announced the opening of an office in Lyon, France to strengthen their relationships with customers locally and throughout Europe.

October 27, 2019
·
1 min read
Drug Development

GeoVax Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV

GeoVax Labs, Inc. announced its participation in a planned clinical trial led by researchers at American Gene Technologies, to develop a therapy aimed at eliminating HIV from infected people..

October 27, 2019
·
4 min read
Biotech Bay

Silicon Valley To Demand Better For Patients, Survival at Purplestride, The Walk To End Pancreatic Cancer

PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and

October 27, 2019
·
2 min read
Merus Bispecific Antibody MCLA-128 Shows Encouraging Early Clinical Activity in Patients with Cancers Harboring NRG1 Gene Fusions

Tumor shrinkage observed in three patients harboring NRG1 fusions (two pancreatic, one non-small cell lung cancer) presented by investigators at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 27, 2019
·
14 min read
Drug Development

Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTAP-Deleted Tumors

Plasma SAM Biomarker Indicates Robust Target Engagement at Well Tolerated Doses; AG-270 Maximum Tolerated Dose Determined to be 200 mg Once Daily

October 27, 2019
·
9 min read
Business

ACEP Selects Dr. Mark Rosenberg as President-Elect

The American College of Emergency Physicians named Mark S. Rosenberg, DO, MBA, FACEP as the new president-elect during ACEP19 in Denver Colorado.

October 27, 2019
·
1 min read